DI AGOSTINO, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 620
AS - Asia 279
EU - Europa 276
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 6
Totale 1.197
Nazione #
US - Stati Uniti d'America 619
SG - Singapore 223
IT - Italia 167
CN - Cina 40
SE - Svezia 38
GB - Regno Unito 20
NL - Olanda 18
EU - Europa 15
DE - Germania 14
CZ - Repubblica Ceca 7
BR - Brasile 4
HK - Hong Kong 4
IN - India 4
FI - Finlandia 3
CL - Cile 2
FR - Francia 2
IL - Israele 2
JP - Giappone 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CA - Canada 1
IR - Iran 1
KW - Kuwait 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.197
Città #
Chandler 121
Santa Clara 72
Singapore 65
Milan 58
Lawrence 57
Princeton 57
Wilmington 35
Ashburn 23
Des Moines 23
Rome 23
Chicago 22
London 17
Boardman 14
Hanover 8
Rende 8
Shanghai 8
West Jordan 8
Olomouc 7
Florence 6
Norwalk 6
Palermo 6
San Nicola Manfredi 6
The Dalles 5
Hong Kong 4
Sesto Fiorentino 4
Vallefiorita 4
Bologna 3
Munich 3
Pune 3
Redmond 3
Salt Lake City 3
São Paulo 3
Amsterdam 2
Assago 2
Aversa 2
Buffalo 2
Dronten 2
Guangzhou 2
Haifa 2
Helsinki 2
Horia 2
Naples 2
Trescore Balneario 2
Albignasego 1
Bari 1
Beijing 1
Catanzaro 1
Council Bluffs 1
Eden Prairie 1
Fremont 1
Grottaglie 1
Kemerovo 1
Košice 1
Kuwait City 1
Manila 1
Marshall 1
Modugno 1
Mountain View 1
Nashville 1
New York 1
North Charleston 1
Oakland 1
Padova 1
Philadelphia 1
Phoenix 1
Reggio Calabria 1
San Francisco 1
Sanming 1
Seattle 1
Shenzhen 1
Spoltore 1
Tokyo 1
Toronto 1
Tottori 1
West Palm Beach 1
Wuxi 1
Xiamen 1
Totale 741
Nome #
Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment 68
Detection of the Lassa Virus in a Group of Odontogenic Bone Tumor Tissues 39
MicroRNAs in head and neck squamous cell carcinoma: A possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 37
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells 36
MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies 34
Arenavirus as a potential etiological agent of odontogenic tumours in humans 31
Genomic instability: The pivotal role of mutant p53 in human cancers 31
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer 30
Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression 30
Circular RNAs in Embryogenesis and Cell Differentiation With a Focus on Cancer Development 29
17-β-estradiol elicits genomic and non-genomic responses in mouse male germ cells 29
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation 29
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence 27
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion 27
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 25
Analysis of the gene expression profile of mouse male meiotic germ cells 25
Gender, mutant p53 and PML: A growing "affaire" in tumor suppression and oncogenesis 23
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 23
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells 23
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 22
The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats 21
Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer 21
HMGA1 and HMGA2 protein expression in mouse spermatogenesis 21
Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation 21
Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy 21
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer 19
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease 19
Mutant p53: An oncogenic transcription factor 19
The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs 19
A Combined atomic force microscopy imaging and docking study to investigate the complex between p53 DNA binding domain and azurin 19
New therapeutic strategies to treat human cancers expressing mutant p53 proteins 18
The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein 18
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 18
PML surfs into HIPPO tumor suppressor pathway 16
Loss of two-pore channel 2 (TPC2) expression increases the metastatic traits of melanoma cells by a mechanism involving the hippo signalling pathway and store-operated calcium entry 16
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma 16
Mutant p53 proteins: Between loss and gain of function 15
Long non-coding MIR205HG depletes Hsa-miR-590-3p leading to unrestrained proliferation in head and neck squamous cell carcinoma 15
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 15
MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer 15
The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1 15
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids: Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery 14
Che-1/miR-590-3p/TAZ axis sustains multiple myeloma disease 14
Interaction of mutant p53 with p73: A Surface Plasmon Resonance and Atomic Force Spectroscopy study 14
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function 14
MiR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer 14
PML, YAP, and p73 Are Components of a Proapoptotic Autoregulatory Feedback Loop 14
New molecular mechanisms and clinical impact of circrnas in human cancer 14
The impact of mutant p53 in the non-coding RNA world 13
The MAPK pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes 13
The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts 13
Prolin-rich tyrosine kinase 2 (PYK2) expression and localization in mouse testis 13
Promyelocytic leukemia protein is required for gain of function by mutant p53 13
The miR-205-5p/BRCA1/RAD17 axis promotes genomic instability in head and neck squamous cell carcinomas 12
Isolation and characterization of three polyamine oxidase genes from Zea mays 12
Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth 12
Oncogenic intra-p53 family member interactions in human cancers 12
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 12
Targeting mutant p53 in cancer: The latest insights 11
Signaling through Extracellular Signal-regulated Kinase Is Required for Spermatogonial Proliferative Response to Stem Cell Factor 11
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 11
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer 10
Maize polyamine oxidase: Primary structure from protein and cDNA sequencing 10
Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop 10
Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments 10
Meiotic progression of isolated mouse spermatocytes under simulated microgravity 9
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine 8
Phosphorylation of High-Mobility Group Protein A2 by Nek2 Kinase during the First Meiotic Division in Mouse Spermatocytes 8
Novel Insights into the Role of the Antioxidants in Prostate Pathology 7
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 5
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis 5
Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer 4
Totale 1.337
Categoria #
all - tutte 20.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 54 0 1 1 3 27 4 4 0
2021/2022177 1 0 2 34 10 12 3 31 14 19 37 14
2022/2023363 122 43 15 33 13 21 7 13 30 33 22 11
2023/2024196 38 14 7 12 12 32 7 10 8 11 18 27
2024/2025507 108 10 11 23 69 84 17 32 127 25 1 0
Totale 1.337